Skip to main content
. Author manuscript; available in PMC: 2013 Apr 23.
Published in final edited form as: J Clin Exp Neuropsychol. 2011 Jun 24;33(7):735–752. doi: 10.1080/13803395.2011.553584

TABLE 1.

Demographic characteristics of sample

MJ−/HIV− (n = 21)
MJ+/HIV− (n = 23)
MJ−/HIV+ (n = 25)
MJ+/HIV+ (n = 17)
M (SD) % Mdn [IQR] M (SD) % Mdn [IQR] M (SD) % Mdn [IQR] M (SD) % Mdn [IQR]
Age (years) 43.0 (6.1) 45.5 (7.8) 43.0 (5.9) 44.4 (7.6)
Education (years) 12.3 (2.1) 11.6 (1.4) 12.0 (2.0) 12.3 (1.7)
AmNART estimated IQ 101.1 (9.0) 104.0 (10.4) 101.1 (9.0) 99.0 (5.5)
% Male 76 87 72 59
Ethnicity/race
 % Caucasian 19 4 8 6
 % Hispanic 5 0 4 6
 % African American 76 96 88 82
 % Other 0 0 0 6
% Right-handed 91 87 96 94
BDI–II * 4 [1, 8] 9 [5, 17] 6 [3, 11] 19 [12, 26]
STAI–State* 32.5 (14.0) 37.7 (11.6) 31.8 (10.1) 45.8 (12.2)
WURS* 34.5 (24.7) 34.4 (16.6) 25.3 (11.6) 40.7 (16.6)
% Hepatitis C seropositive 19 35 36 47

Note. Mdn, median; IQR, interquartile range; MJ, marijuana; AmNART, American National Adult Reading Test; BDI–II, Beck Depression Inventory–Second Edition; STAI–State, State–Trait Anxiety Inventory–State portion; WURS, Wender–Utah Rating Scale.

*

p < .05; BDI–II: MJ+/HIV+ > MJ+/HIV−, MJ−/HIV+, MJ+/HIV+; STAI-State: MJ+/HIV+ > MJ−/HIV+, MJ−/HIV−; WURS: HIV+/MJ+ > HIV+/MJ−.